Refers to a Bi specific Antibody anti EGFL7 comprising a variable Domain comprises: (a) a hypervariable region of light chain selected SEC ID no. 193, 194, 210, 211, 212, 222, 223, 224 and 201, 202, 203 and 204 (b) a hypervariable region of heavy chain selected s CE id no. 213, 214, 215, 225, 226, 227, 195, 196, 197, 198, 200, 220, 216, 217, 218 and 219.Also refers to a Pharmaceutical composition containing Said Antibody and is useful in the treatment of cancer, a tumor, or a cell proliferative DisorderSE REFIERE A UN ANTICUERPO BIESPECIFICO ANTI-EGFL7 QUE COMPRENDE UN DOMINIO VARIABLE QUE COMPRENDE: (A) UNA REGION HIPERVARIABLE DE CADENA LIGERA SELECCIONADA DE SEC ID NºS 193, 194, 210, 211, 212, 222, 223, 224 Y 201, 202, 203 Y 204 (B) UNA REGION HIPERVARIABLE DE CADENA PESADA SELECCIONADA DE SEC ID NºS 213, 214, 215, 225, 226, 227 Y 195, 196, 197, 198, 200, 220, 216, 217, 218 Y 219. REFERIDA ADEMAS A UNA COMPOSICION FARMACEUTICA QUE CONTIENE DICHO ANTICUERPO Y ES UTIL EN EL TRATAMIENTO DEL CANCER, UN TUMOR O UN TRANSTORNO PROLIFERATIVO CELULAR
